, Tracking Stock Market Picks
Enter Symbol:
The Medicines Company (MDCO) [hlAlert]

down 2.42 %

The Medicines Company (MDCO) rated Buy with price target $38 by WallachBeth

Posted on: Thursday,  Feb 21, 2013  8:25 AM ET by WallachBeth

WallachBeth rated Buy The Medicines Company (NASDAQ: MDCO) on 02/21/2013, when the stock price was $32.54. Since
then, The Medicines Company has lost 2.43% as of 01/15/2016's recent price of $31.75.
If you would have followed this WallachBeth's recommendation on MDCO, you would have lost 2.42% of your investment in 1058 days.

The Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The Company has two marketed products, Angiomax (bivalirudin) and Cleviprex (clevidipine butyrate) injectable emulsion, two products in late-stage development, cangrelor and oritavancin, which the Company acquired in February 2009, and one compound, CU-2010, scheduled to enter clinical development during 2009.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/21/2013 8:25 AM Buy
32.54 38.00
as of 12/13/2013
1 Week down  -3.42 %
1 Month down  -1.94 %
3 Months up  6.80 %
1 YTD up  13.36 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy